Anduril’s valuation offers a hopeful signal for Northrop Grumman and other defense contractors after a steep stock selloff.
Neurocrine Biosciences has retreated from its all-time high, creating a buying opportunity for the next phase of growth.
Rocket Lab’s larger rocket won’t take flight until 2027. That’s behind schedule. Investors aren’t impressed.
US wholesale inflation surged past analysts' expectations in September, marking its biggest jump since 2022 as the war in Iran sent fuel prices rocketing, government data showed Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results